139 related articles for article (PubMed ID: 35749783)
1. Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review.
Rebhan K; Wasinger G; Hassler MR; Shariat SF; Compérat EM
Curr Opin Urol; 2022 Jul; 32(4):358-363. PubMed ID: 35749783
[TBL] [Abstract][Full Text] [Related]
2. [Basal cell carcinoma of prostate: a report of three cases].
Liu Z; Ma LL; Zhang SD; Lu M; Tian Y; He Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):720-724. PubMed ID: 29263520
[TBL] [Abstract][Full Text] [Related]
3. Basal Cell Carcinoma of Prostate With MSMB-NCOA4 Fusion and a Probable Basal Cell Carcinoma In Situ: Case Report.
Pedersen V; Petersen KS; Brasso K; Østrup O; Loya AC
Int J Surg Pathol; 2021 Dec; 29(8):850-855. PubMed ID: 33978524
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma of the prostate: report of a case and review of the published reports.
Segawa N; Tsuji M; Nishida T; Takahara K; Azuma H; Katsuoka Y
Int J Urol; 2008 Jun; 15(6):557-9. PubMed ID: 18489650
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinoma of the prostate: a case report of a rare prostate cancer and review of the literature.
Puglisi S; Cremante M; Rescigno P; Gandini A; Zanardi E; Fornarini G; Rebuzzi SE
Acta Biomed; 2023 Aug; 94(S1):e2023232. PubMed ID: 37606060
[TBL] [Abstract][Full Text] [Related]
6. An Unusual Case of Metastatic Basal Cell Carcinoma of the Prostate: A Case Report and Literature Review.
Dong S; Liu Q; Xu Z; Wang H
Front Oncol; 2020; 10():859. PubMed ID: 32537438
[No Abstract] [Full Text] [Related]
7. FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer.
Chiodelli P; Coltrini D; Turati M; Cerasuolo M; Maccarinelli F; Rezzola S; Grillo E; Giacomini A; Taranto S; Mussi S; Ligresti A; Presta M; Ronca R
Cancer Lett; 2022 Feb; 526():217-224. PubMed ID: 34861311
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma of the prostate: A case report and review of the literature.
Shibuya T; Takahashi G; Kan T
Mol Clin Oncol; 2019 Jan; 10(1):101-104. PubMed ID: 30655983
[TBL] [Abstract][Full Text] [Related]
9. Genomic Characterization of Prostatic Basal Cell Carcinoma.
Low JY; Ko M; Hanratty B; Patel RA; Bhamidipati A; Heaphy CM; Sayar E; Lee JK; Li S; De Marzo AM; Nelson WG; Gupta A; Yegnasubramanian S; Ha G; Epstein JI; Haffner MC
Am J Pathol; 2023 Jan; 193(1):4-10. PubMed ID: 36309102
[TBL] [Abstract][Full Text] [Related]
10. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
[TBL] [Abstract][Full Text] [Related]
11. Pigmented basal cell carcinoma of the nipple: a case report and review of the literature.
Brown PJ; Milch JM; Hivnor CM
Cutis; 2013 Nov; 92(5):253-7. PubMed ID: 24343213
[TBL] [Abstract][Full Text] [Related]
12. Implication of wide surgical excision in minimizing positive margins and consequential secondary excision - a retrospective comparative study involving 106 basal cell carcinoma cases.
Kundnani NR; Tirziu RV; Borza C; Tirziu C; Sharma A; Rosca CI; Baderca F; Paul C; Solovan CS; Blidisel A
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4283-4288. PubMed ID: 34227063
[TBL] [Abstract][Full Text] [Related]
13. Extended lymphadenectomy for high-risk prostate cancer in patients with chronic lymphocytic leukemia may not be necessary: a report of two cases.
Zhu Y; Wang Y; Qian Z; Pan J; Liu Q; Dong B; Xue W
BMC Cancer; 2019 Jul; 19(1):676. PubMed ID: 31288785
[TBL] [Abstract][Full Text] [Related]
14. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
15. Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
Sivaraman A; Benfante N; Touijer K; Coleman J; Scardino P; Laudone V; Eastham J
Investig Clin Urol; 2018 Mar; 59(2):83-90. PubMed ID: 29520383
[TBL] [Abstract][Full Text] [Related]
16. Nasal Basal Cell Carcinoma with Matrical Differentiation: Risk of Metastasis and Impact on Management.
Maroun C; Alam E; Khalifeh I; Abbas O; Moukarbel RV
Head Neck Pathol; 2017 Jun; 11(2):228-233. PubMed ID: 27306383
[TBL] [Abstract][Full Text] [Related]
17. Basal cell carcinoma on the dorsum of the foot with inguinal and pelvic lymph nodes metastases.
Nakamura Y; Ishitsuka Y; Ohara K; Otsuka F
Int J Dermatol; 2012 Sep; 51(9):1068-73. PubMed ID: 22909360
[TBL] [Abstract][Full Text] [Related]
18. Basal cell carcinoma of the prostate gland: a case report and brief review of the basal cell proliferations of the prostate gland.
Bohn OL; Rios-Luna NP; Navarro L; Duran-Peña A; Sanchez-Sosa S
Ann Diagn Pathol; 2010 Oct; 14(5):365-8. PubMed ID: 20850702
[TBL] [Abstract][Full Text] [Related]
19. Palmar basal cell carcinoma: case report and literature review.
Salomão P; Kopke LF; MacHado-Pinto J
Dermatol Surg; 1999 Nov; 25(11):908-10. PubMed ID: 10594608
[TBL] [Abstract][Full Text] [Related]
20. Axillary basal cell carcinoma: case report and literature review.
Lin CT; Chen SG; Chen TM; Chang SC
Acta Dermatovenerol Croat; 2011; 19(2):107-9. PubMed ID: 21703158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
